National Vision Holdings Inc header image

National Vision Holdings Inc

EYE

Equity

ISIN US63845R1077 / Valor 38523646

NASDAQ (2024-09-18)
USD 10.99-0.72%

National Vision Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

National Vision Holdings Inc is a rapidly expanding optical retail company in the United States, operating a network of over 1,100 stores across 38 states and Puerto Rico. The company offers a wide range of eyewear products and services, catering to the vision needs of a diverse customer base. With a strong presence in the market, National Vision Holdings Inc continues to grow and innovate in the optical industry, providing quality eyewear solutions to its customers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Revenue Growth

National Vision Holdings Inc. reported net revenue of $506.4 million for the fourth quarter of 2023, marking an 8.0% increase from Q4 2022. This growth was primarily driven by an increase in Adjusted Comparable Store Sales Growth and new store sales, partially offset by store closures.

Comparable Store Sales

For the fourth quarter of 2023, National Vision Holdings Inc. achieved a comparable store sales growth of 6.0% and an Adjusted Comparable Store Sales Growth of 5.7% compared to Q4 2022. This growth reflects an increase in customer transactions and higher average ticket values.

Net Loss

National Vision Holdings Inc. reported a net loss of $(16.0) million for the fourth quarter of 2023, with a diluted EPS of $(0.20). This includes $4.9 million in expenses related to the termination of the Walmart partnership, compared to a net loss of $(9.3) million and diluted EPS of $(0.12) in Q4 2022.

Adjusted Operating Income

In the fourth quarter of 2023, National Vision Holdings Inc. reported an Adjusted Operating Income of $0.3 million, a significant improvement compared to $(6.8) million in Q4 2022. This improvement was driven by disciplined expense management and effective marketing campaigns.

Fiscal Year 2023 Performance

For the fiscal year 2023, National Vision Holdings Inc. reported net revenue of $2,126.5 million, a 6.0% increase from fiscal year 2022. The company also reported a net loss of $(65.9) million, inclusive of $79.7 million in non-cash impairment charges and $7.0 million in expenses related to the termination of the Walmart partnership, compared to a net income of $42.1 million in fiscal year 2022.

Summarized from source with an LLMView Source

Key figures

-33.5%1Y
-81.3%3Y
-58.6%5Y

Performance

48.5%1Y
57.3%3Y
59.8%5Y

Volatility

Market cap

1844 M

Market cap (USD)

Daily traded volume (Shares)

782,152

Daily traded volume (Shares)

1 day high/low

11.52 / 10.93

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.55%USD 74.70
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.49%USD 32.16
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.65%USD 2.62
Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc Arrowhead Pharmaceuticals Inc Valor: 32193461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.85%USD 20.78
Evotec SE
Evotec SE Evotec SE Valor: 3979578
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 3.64
Staar Surgical Co
Staar Surgical Co Staar Surgical Co Valor: 972813
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.45%USD 31.39
Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.53%USD 24.44
AbCellera Biologics Inc
AbCellera Biologics Inc AbCellera Biologics Inc Valor: 58489933
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.73%USD 2.75
InMode Ltd.
InMode Ltd. InMode Ltd. Valor: 49023508
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.52%USD 17.46
Revance Therapeutics Inc
Revance Therapeutics Inc Revance Therapeutics Inc Valor: 23239569
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%USD 5.99